All News Faes Farma, S.A.

Equities

Market Closed - BME Other stock markets 11:35:26 2024-04-26 am EDT			After market 12:32:27 pm
3.38 ^EUR	+1.81%		3.385	+0.15%

05:34pm	FAES FARMA : Q1 beat; full-year guidance re-affirmed
Feb. 27	FAES FARMA : Q4 profitability exceeded expectations

FAES FARMA : Q1 beat; full-year guidance re-affirmed	11:34am
FAES FARMA : Q4 profitability exceeded expectations	Feb. 27
Faes Farma, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Ex-dividend day for interim dividend	Jan. 10	FA
FAES FARMA : Mixed Q3; markets need more from Faes to be convinced	23-10-25
Faes Farma, S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-14	CI
FAES FARMA : A soft Q2, as expected; guidance maintained	23-08-01
Faes Farma, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-28	CI
FAES FARMA : Increased R&D focus and inflationary pressures to hold back near-to-medium term earnings	23-07-12
FAES FARMA : A healthy start to 2023	23-05-08
Faes Farma, S.A. completed the acquisition of NovoSci.	23-05-02	CI
Faes Farma, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-02	CI
Ex-dividend day for Cash amount paid with the scrip issue offered as an alternative to the dividend	23-04-11	FA
FAES FARMA : 2022 guidance met + positive view maintained	23-03-06
Faes Farma, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-28	CI
Faes Farma, S.A. agreed to acquire NovoSci.	23-01-11	CI
Ex-dividend day for interim dividend	23-01-04	FA
Roche’s Alzheimer’s failure has sector-wide implications	22-11-14
Faes Farma, S.A. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-11-02	CI
FAES FARMA : Soft Q3, but 2022 guidance maintained	22-10-28

No results for this search

FAES FARMA : Q1 beat; full-year guidance re-affirmed

April 26, 2024 at 11:34 am EDT